Brief report: β-blocker use among veterans with systolic heart failure

Journal of General Internal Medicine

Volumn 21, Issue 12, 2006, Pages 1306-1309

  Sinha, Sanjai ^a,b,d   Goldstein, Matthew ^b   Penrod, Joan ^a,b   Hochman, Tsivia ^a   Kamran, Mohammad ^a   Tenner, Craig ^a,c   Cohen, Gabriela ^a,c   Schwartz, Mark D ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA New York Harbor Healthcare System ^*  (United States)

Author keywords

blockers; Guideline adherence; Heart failure; Prescription rates; Utilization

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; PROPRANOLOL DERIVATIVE; SPIRONOLACTONE;

AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEPRESSION; HEART EJECTION FRACTION; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIMARY MEDICAL CARE; VETERAN;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; AGED, 80 AND OVER; ASTHMA; CARDIAC OUTPUT, LOW; DEPRESSION; HOSPITALS, VETERANS; HUMANS; MIDDLE AGED; PRESCRIPTIONS, DRUG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; STROKE VOLUME; SYSTOLE; VETERANS;

EID: 33750512976     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2006.00601.x     Document Type: Article

References (21)

1. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9-13.
2. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-7.
3. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol hear failure study group. N Engl J Med. 1996;334:1349-55.
4. Ansari M, Alexander M, Tutar A, Bello D, Massie BM. Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting. J Am Coll Cardiol. 2003;41:62-8.
5. Gupta R, Tang WH, Young JB. Patterns of beta-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinic. Am Heart J. 2004;147:79-83.
6. Hulsmann M, Berger R, Mortl D, Pacher R. Influence of age and in-patient care on prescription rate and long-term outcome in chronic heart failure: a data-based substudy of the euroheart failure survey. Eur J Heart Failure. 2005;7:657-61.
7. Maggioni AP, Sinagra G, Opasich C, et al. Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. Heart. 2003;89:299-305.
8. Ross J Jr., Braunwald E. Studies on starling's law of the heart. Ix. the effects of impeding venous return on performance of the normal and failing human left ventricle. Circulation. 1964;30:719-27.
9. Rutten FH, Grobbee DE, Hoes AW. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Failure. 2003;5:337-44.
10. Kimmelstiel C, Levine D, Perry K, et al. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial. Circulation. 2004;110:1450-5.
11. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005;128:2640-6.
12. Salpeter SR, Ormiston TM, Salpeter EE. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med. 2002;137:715-25.
13. Bobbio M, Ferrua S, Opasich C, et al. Survival and hospitalization in heart failure patients with or without diabetes treated with beta-blockers. J Cardiac Failure. 2003;9:192-202.
14. Fleiss J. Statistical Methods for Rates and Proportions. 2nd edn. New York: Wiley; 1981.
15. Patel JA, Fotis MA. Comparison of treatment of patients with congestive heart failure by cardiologists versus noncardiologists. Am J Health Syst Pharm. 2005;62:168-72.
16. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489-97.
17. Solomon SD, Anavekar N, Skali H, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112:3738-44.
18. Lee DS, Mamdani MM, Austin PC, et al. Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. Am J Med. 2004;116:581-9.
19. Kotlyar E, Keogh AM, Macdonald PS, Arnold RH, McCaffrey DJ, Glanville AR. Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma. J Heart Lung Transplant. 2002;21:1290-5.
20. Krum H, Hill J, Fruhwald F, et al. Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study. Eur J Heart Fail. 2006;8:302-7.
21. Asch SM, McGlynn EA, Hogan MM, et al. Comparison of quality of care for patients in the Veterans health administration and patients in a national sample. Ann Intern Med. 2004;141:938-45.